New hope for stomach cancer? triple therapy shows promise in early trial
NCT ID NCT05379972
First seen May 04, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This study tests a new treatment approach for people with advanced stomach or gastroesophageal junction cancer that has spread. Participants first receive targeted radiation and a drug called olaparib, followed by a combination of olaparib and pembrolizumab. The goal is to see if this treatment can shrink tumors that were not directly irradiated. The trial enrolled 9 adults who had already tried at least one prior therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCHealth Highlands Ranch Hospital
Highlands Ranch, Colorado, 80129, United States
-
UCHealth Memorial Hospital Central
Colorado Spring, Colorado, 80909, United States
-
UCHealth Memorial Hospital North
Colorado Springs, Colorado, 80909, United States
-
University of Colorado Health
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.